Colgate-Palmolive (NYSE:CL) is a leading consumer products company known for its strong presence in oral care, pet nutrition, and other personal care products. The company operates globally, with significant market share in various regions. Colgate's competitors include Procter & Gamble and Unilever, which also dominate the consumer goods sector.
On January 30, 2026, Piper Sandler raised Colgate-Palmolive's price target to $96, indicating a potential 7.32% increase from its current trading price of $89.45. This optimistic outlook aligns with Colgate's strong financial performance in the fourth quarter of 2025, where the company reported earnings per share of $0.95, surpassing the Zacks Consensus Estimate of $0.91.
Colgate-Palmolive's net sales for the fourth quarter rose by 5.8% to $5.23 billion, exceeding expectations by 2.79%. This growth was driven by a 2.7% increase in pricing, which helped offset volume declines in some regions. Latin America played a crucial role, with a 6.5% growth in organic sales, supported by higher pricing, increased volumes, and favorable currency effects.
The company's robust demand in oral care and pet nutrition, along with strong global demand, contributed to its impressive financial results. Colgate-Palmolive has consistently outperformed consensus EPS estimates over the past four quarters, reinforcing investor confidence in its ability to deliver favorable returns.
Currently, Colgate-Palmolive's stock is priced at $89.59, reflecting a 5.10% increase. The stock has fluctuated between $87.70 and $90.71 during the day, with a 52-week high of $100.18 and a low of $74.55. With a market capitalization of approximately $72.22 billion and a trading volume of 9.24 million shares, Colgate-Palmolive remains a key player in the consumer products industry.
